Psychedelic Therapy
How psychedelic-assisted therapy may complement ongoing mental health care
As psychedelic-assisted therapies continue advancing through clinical research, understanding how they fit within existing mental health care systems is increasingly important.
How psychedelic treatment could transform veteran care
Why veterans’ trauma requires new therapeutic approaches.
Research explores how psilocybin-assisted group therapy addresses existential distress in cancer patients
New findings that deepen understanding of how psilocybin-assisted group therapy can help people with cancer and depression.
Sunstone’s 2Dose Study: Advancing psilocybin-assisted therapy in cancer care
This clinical trial will explore whether psilocybin is more effective than an active placebo and if two doses are better than one.
Research Highlights Meaning-Centered Psychotherapy as Promising Partner for Psilocybin Therapy in Cancer Care
A new paper published in Psychedelic Medicine introduces a novel model combining Meaning-Centered Psychotherapy (MCP) with psilocybin-assisted therapy (PAT) for patients with advanced cancer and depression. Developed from Sunstone Therapies’ investigator-initiated trial, the approach—called MCP-PSIL—aims to help patients reduce distress and find deeper meaning while navigating serious illness.
Advancing Psychedelic-Assisted Therapy: Insights from Sunstone’s Latest Research
Co-founder and CEO, Dr. Manish Agrawal, recently shared his expertise and vision for the future of psychedelic-assisted therapy in oncology in a four-part interview series with Pharmacy Times' Lead Editor, Alana Hippensteele.
Why mental health care is also cancer care
Psychedelic-assisted therapies bring a critical new dimension to questions about subjectivity in psychiatry.
Psychedelics: subjectivity in the therapeutic response
Psychedelic-assisted therapies bring a critical new dimension to questions about subjectivity in psychiatry.
How psychedelics can unlock new care in oncology
Dr. Manish Agrawal speaks PATs ability to treat not just the physical manifestations of cancer but also the mental and emotional toll it takes on patients.
Publication of Sunstone Data on Use of Psilocybin Therapy for Patients with Cancer and Major Depression Disorder, in JAMA Oncology
Sunstone Therapies announces publication of positive data on use of Psilocybin Therapy for patients with cancer and major depression disorder